Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient.

Abstract

1. The case is described of a 28-year old male with a diagnosis of Lesch-Nyhan syndrome. 2. Chronic treatment with the atypical neuroleptic risperidone at 4 mg daily has maintained a significant reduction in occurrence of self-mutilation.

• Authors: S M Allen, S N Rice
• Journal: Progress in neuro-psychopharmacology & biological psychiatry (Prog Neuropsychopharmacol Biol Psychiatry) Vol. 20 Issue 5 Pg. 793-800 (Jul 1996) ISSN: 0278-5846 [Print] England
• PMID: 8870064 (Publication Type: Case Reports, Journal Article)

Chemical References

• Dopamine Antagonists
• Risperidone

Topics

• Adult
• Dopamine Antagonists (therapeutic use)
• Humans
• Lesch-Nyhan Syndrome (complications, drug therapy, psychology)
• Male
• Risperidone (therapeutic use)
• Self Mutilation (drug therapy, etiology)